menthoxypropanediol
Small moleculeexperimental
Menthoxypropanediol, is a synthetic derivative of menthol. While the cooling strength of 3-(l-menthoxy)propane-1,2-diol is accepted as being about 20–25% that of menthol, it is also noted that "in a Vaseline ointment, 3-(l-menthoxy)propane-1,2-diol shows a cool feeling 2.0 to 2.5 times stronger than that of l-menthol". It is used in various cosmetic chemical concoctions. — Wikipedia
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 5, 2012 (NCT01603303)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaMenthoxypropanediol ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03610386 | N/A | Aug 1, 2018 | Beiersdorf, University of Western Brittany |
| NCT01603303 | Phase 2 | Dec 5, 2012 | Fidia Advanced Biopolymers, University of Texas at Houston |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Beiersdorf | For profit | 1 | 0 | 1 | 2018 |
| Fidia Advanced Biopolymers | For profit | 1 | 0 | 1 | 2012 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 2012 |
| University of Western Brittany | Academic/Hospital | 1 | 1 | 1 | 2018 |
4 organizations
Page 1 / 1